Enveric Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADVISORSHARES INVESTMENTS LLC | 02/14/2025 | 599.85 K | $214.99 K | 63.43% | 6.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 216.59 K | $77.63 K | -0.60% | 2.49% |
| UBS GROUP AG | 02/14/2025 | 78.41 K | $28.07 K | 10,626.13% | 0.90% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 55.76 K | $20.00 K | 141.22% | 0.64% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 31.87 K | $11.42 K | 4.05% | 0.37% |
| XTX TOPCO LTD | 02/13/2025 | 22.01 K | $7.89 K | 100.00% | 0.25% |
| VANGUARD GROUP INC | 02/11/2025 | 18.20 K | $6.52 K | 0.00% | 0.21% |
| CITADEL ADVISORS LLC | 02/14/2025 | 15.02 K | $5.38 K | 17.75% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 12.15 K | $4.35 K | -9.26% | 0.14% |
| JANE STREET GROUP, LLC | 02/14/2025 | 10.82 K | $3.88 K | 100.00% | 0.12% |
| BLACKROCK, INC. | 02/07/2025 | 9.01 K | $3.23 K | 0.00% | 0.10% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 8.81 K | $3.15 K | -49.29% | 0.10% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 273 | $98 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 180 | $65 | 4.05% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 150 | $70 | -73.91% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 70 | $25 | -1.41% | 0.00% |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 01/17/2025 | 50 | $17 | 0.00% | 0.00% |
| 02/06/2025 | 19 | $7 | 100.00% | 0.00% | |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 16 | $6 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enveric Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of Enveric Biosciences, Inc.. The most heavily invested institutionals were:
Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 0
XTX Topco Ltd: 0
WELLS FARGO & COMPANY/MN: 0
AdvisorShares Investments LLC: 0
CITADEL ADVISORS LLC: 0
NATIONAL BANK OF CANADA /FI/: 0
12.40% of Enveric Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.58 K shares in the last 24 months. This purchase volume represents approximately $34.90 K in transactions.